3-[[(3aR,4R,6R,6aR)-4-methoxy-2,2-dimethyl-3a,4,6,6a-tetrahydrofuro[3,4-d][1,3]dioxol-6-yl]methoxy]-2,2-dimethyl-3H-benzo[g]benzofuran-4,5-dione

ID: ALA5184425

PubChem CID: 71525254

Max Phase: Preclinical

Molecular Formula: C23H26O8

Molecular Weight: 430.45

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CO[C@@H]1O[C@H](COC2C3=C(OC2(C)C)c2ccccc2C(=O)C3=O)[C@H]2OC(C)(C)O[C@@H]12

Standard InChI:  InChI=1S/C23H26O8/c1-22(2)20(14-16(25)15(24)11-8-6-7-9-12(11)17(14)29-22)27-10-13-18-19(21(26-5)28-13)31-23(3,4)30-18/h6-9,13,18-21H,10H2,1-5H3/t13-,18-,19-,20?,21-/m1/s1

Standard InChI Key:  AMDWNEOUUQNSLQ-HDWZVLIESA-N

Molfile:  

 
     RDKit          2D

 33 37  0  0  0  0  0  0  0  0999 V2000
   -4.0612    1.2257    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3466    1.6379    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6346    1.2261    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6346    0.4008    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3447   -0.0108    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0612    0.3970    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9198   -0.0117    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2051    0.4008    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2051    1.2261    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9198    1.6387    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9198    2.4640    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4903    1.6387    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7483   -0.8188    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5920   -0.1513    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9277   -0.9051    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9277   -1.7304    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1306   -1.1187    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2050    0.0622    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.7886   -0.5213    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5858   -0.3077    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8814    0.4623    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.7052    0.4191    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9187   -0.3775    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2268   -0.8268    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2887    1.0027    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.0752    1.7999    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4403   -1.6236    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.5597   -0.8967    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.2640   -1.6668    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4776   -2.4640    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0612   -1.8804    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7159   -0.1639    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
    1.6433   -1.4104    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  2  1  0
  4  3  2  0
  5  4  1  0
  1  6  1  0
  6  5  2  0
  4  7  1  0
  7  8  2  0
  8  9  1  0
  3 10  1  0
  9 10  1  0
 10 11  2  0
  9 12  2  0
  7 13  1  0
  8 14  1  0
 14 15  1  0
 15 13  1  0
 15 16  1  0
 15 17  1  0
 14 18  1  0
 18 19  1  0
 20 19  1  1
 21 20  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 20  1  0
 22 25  1  1
 25 26  1  0
 24 27  1  0
 23 28  1  0
 28 29  1  0
 29 27  1  0
 29 30  1  0
 29 31  1  0
 23 32  1  1
 24 33  1  1
M  END

Associated Targets(Human)

OVCAR-8 (47708 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SF-295 (48000 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HCT-116 (91556 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HL-60 (67320 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 430.45Molecular Weight (Monoisotopic): 430.1628AlogP: 2.25#Rotatable Bonds: 4
Polar Surface Area: 89.52Molecular Species: NEUTRALHBA: 8HBD:
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: 2.47CX LogD: 2.47
Aromatic Rings: 1Heavy Atoms: 31QED Weighted: 0.67Np Likeness Score: 1.54

References

1. Gong Q, Hu J, Wang P, Li X, Zhang X..  (2021)  A comprehensive review on β-lapachone: Mechanisms, structural modifications, and therapeutic potentials.,  210  [PMID:33158575] [10.1016/j.ejmech.2020.112962]

Source